Literature DB >> 27533782

The role of the semaphorins in cancer.

Gera Neufeld1, Yelena Mumblat1, Tatyana Smolkin1, Shira Toledano1, Inbal Nir-Zvi1, Keren Ziv1, Ofra Kessler1.   

Abstract

The semaphorins were initially characterized as axon guidance factors, but have subsequently been implicated also in the regulation of immune responses, angiogenesis, organ formation, and a variety of additional physiological and developmental functions. The semaphorin family contains more then 20 genes divided into 7 subfamilies, all of which contain the signature sema domain. The semaphorins transduce signals by binding to receptors belonging to the neuropilin or plexin families. Additional receptors which form complexes with these primary semaphorin receptors are also frequently involved in semaphorin signaling. Recent evidence suggests that semaphorins also fulfill important roles in the etiology of multiple forms of cancer. Some semaphorins have been found to function as bona-fide tumor suppressors and to inhibit tumor progression by various mechanisms while other semaphorins function as inducers and promoters of tumor progression.

Entities:  

Keywords:  angiogenesis; cancer; lymphangiogenesis; semaphorins

Mesh:

Substances:

Year:  2016        PMID: 27533782      PMCID: PMC5160032          DOI: 10.1080/19336918.2016.1197478

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  262 in total

1.  Semaphorin 5A, an axon guidance molecule, enhances the invasion and metastasis of human gastric cancer through activation of MMP9.

Authors:  Guoqing Pan; Xiangling Zhang; Junyu Ren; Jianbo Lu; Wenliang Li; Hongmei Fu; Shufang Zhang; Jun Li
Journal:  Pathol Oncol Res       Date:  2012-07-21       Impact factor: 3.201

2.  Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.

Authors:  Diane R Bielenberg; Yasuhiro Hida; Akio Shimizu; Arja Kaipainen; Michael Kreuter; Caroline Choi Kim; Michael Klagsbrun
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

4.  Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.

Authors:  Ying Chen; Lei Zhang; Rui Lv; Wen-Qi Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  Cancer-related axonogenesis and neurogenesis in prostate cancer.

Authors:  Gustavo E Ayala; Hong Dai; Michael Powell; Rile Li; Yi Ding; Thomas M Wheeler; David Shine; Dov Kadmon; Timothy Thompson; Brian J Miles; Michael M Ittmann; David Rowley
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

6.  High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.

Authors:  Prakash N Nair; Linda McArdle; John Cornell; Susan L Cohn; Raymond L Stallings
Journal:  Cancer Genet Cytogenet       Date:  2007-04-15

7.  Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Authors:  Claudia Prahst; Mélanie Héroult; Anthony A Lanahan; Noa Uziel; Ofra Kessler; Niva Shraga-Heled; Michael Simons; Gera Neufeld; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

8.  Sema4A induces cell morphological changes through B-type plexin-mediated signaling.

Authors:  Kazunori Yukawa; Tetsuji Tanaka; Kenji Yoshida; Noriko Takeuchi; Takuji Ito; Hyota Takamatsu; Hitoshi Kikutani; Atsushi Kumanogoh
Journal:  Int J Mol Med       Date:  2010-02       Impact factor: 4.101

9.  A requirement for neuropilin-1 in embryonic vessel formation.

Authors:  T Kawasaki; T Kitsukawa; Y Bekku; Y Matsuda; M Sanbo; T Yagi; H Fujisawa
Journal:  Development       Date:  1999-11       Impact factor: 6.868

10.  Astrogliosis Induced by Brain Injury Is Regulated by Sema4B Phosphorylation

Authors:  Liat Ben-Gigi; Sahar Sweetat; Elazar Besser; Yakov Fellig; Thorsten Wiederhold; Roberto D Polakiewicz; Oded Behar
Journal:  eNeuro       Date:  2015-05-25
View more
  32 in total

1.  Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.

Authors:  Sabag D Adi; Nasren Eiza; Jacob Bejar; Hila Shefer; Shira Toledano; Ofra Kessler; Gera Neufeld; Elias Toubi; Zahava Vadasz
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

Review 2.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

3.  Inhibition of semaphorin 4D enhances chemosensitivity by increasing 5-fluorouracile-induced apoptosis in colorectal cancer cells.

Authors:  Golnaz Rashidi; Mahsa Rezaeepoor; Chiman Mohammadi; Ghasem Solgi; Rezvan Najafi
Journal:  Mol Biol Rep       Date:  2020-09-04       Impact factor: 2.316

4.  GIPC proteins negatively modulate Plexind1 signaling during vascular development.

Authors:  Jorge Carretero-Ortega; Zinal Chhangawala; Shane Hunt; Carlos Narvaez; Javier Menéndez-González; Carl M Gay; Tomasz Zygmunt; Xiaochun Li; Jesús Torres-Vázquez
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

5.  Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.

Authors:  Noelle R Jurcak; Agnieszka A Rucki; Stephen Muth; Elizabeth Thompson; Rajni Sharma; Ding Ding; Qingfeng Zhu; James R Eshleman; Robert A Anders; Elizabeth M Jaffee; Kenji Fujiwara; Lei Zheng
Journal:  Gastroenterology       Date:  2019-06-01       Impact factor: 33.883

6.  Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer.

Authors:  Emilie Evanno; Julie Godet; Nathalie Piccirilli; Joëlle Guilhot; Serge Milin; Jean Marc Gombert; Benoit Fouchaq; Joëlle Roche
Journal:  Clin Epigenetics       Date:  2017-08-08       Impact factor: 6.551

7.  Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.

Authors:  Sugandha Saxena; Yuri Hayashi; Lingyun Wu; Mohammad Awaji; Pranita Atri; Michelle L Varney; Abhilasha Purohit; Satyanarayana Rachagani; Surinder K Batra; Rakesh K Singh
Journal:  Oncotarget       Date:  2017-12-23

8.  Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma.

Authors:  Janine Hensel; Antoinette Wetterwald; Ramzi Temanni; Irene Keller; Carsten Riether; Gabri van der Pluijm; Marco G Cecchini; George N Thalmann
Journal:  Oncotarget       Date:  2018-06-22

9.  Hormonal Regulation of Semaphorin 7a in ER+ Breast Cancer Drives Therapeutic Resistance.

Authors:  Lyndsey S Crump; Garhett L Wyatt; Taylor R Rutherford; Jennifer K Richer; Weston W Porter; Traci R Lyons
Journal:  Cancer Res       Date:  2020-10-29       Impact factor: 13.312

10.  Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.

Authors:  Margaret Stromecki; Nazanin Tatari; Ludivine Coudière Morrison; Ravinder Kaur; Jamie Zagozewski; Gareth Palidwor; Vijay Ramaswamy; Patryk Skowron; Matthias Wölfl; Till Milde; Marc R Del Bigio; Michael D Taylor; Tamra E Werbowetski-Ogilvie
Journal:  Mol Oncol       Date:  2018-03-01       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.